Rhodes Pharmaceuticals LLC
NDC labeler code: 42858
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfateAdderall, Mixed Salts of a Single Entity Amphetamine Product XR, Adderall XR · 13 products
- Morphine sulfateMs Contin, Mitigo, Duramorph · 8 products
- Hydromorphone hydrochlorideDilaudid · 8 products
- Lisdexamfetamine dimesylateVyvanse, Arynta · 7 products
- BuprenorphineBelbuca, Brixadi, Buprenorphine Transdermal System · 7 products
- MethylphenidateMetadate Cd, Relexxii, Methylphenidate Hydrochloride Cd · 7 products
- Oxycodone hydrochlorideOxycontin, Roxybond, Roxicodone · 5 products
- Oxycodone and acetaminophenEndocet, Prolate, Percocet · 3 products
- Hydrocodone bitartrate and acetaminophenNorco · 3 products
- Buprenorphine and naloxoneZubsolv, Buprenorphine and Naloxone Sublingual Film, Suboxone · 2 products
- FenofibrateAntara, Lipofen, Tricor · 2 products
- MaravirocSelzentry · 2 products
- ScopolamineScopolamine Trandermal System, Transderm Scop · 1 product
FDA applications for these products
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| November 4, 2025 | ANDA216143 | Maraviroc MARAVIROC | Rhodes Pharms |
| May 6, 2024 | ANDA215329 | Scopolamine SCOPOLAMINE | Rhodes Pharms |
| August 25, 2023 | ANDA215330 | Lisdexamfetamine dimesylate LISDEXAMFETAMINE DIMESYLATE | Rhodes Pharms |
| January 13, 2021 | ANDA213111 | Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE | Rhodes Pharms |
| March 30, 2020 | ANDA205601 | Buprenorphine and naloxone BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | Rhodes Pharms |
| May 17, 2019 | ANDA210651 | Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE | Rhodes Pharms |
| March 27, 2017 | ANDA207276 | Buprenorphine BUPRENORPHINE HYDROCHLORIDE | Rhodes Pharms |
| April 12, 2016 | ANDA202991 | Hydrocodone bitartrate and acetaminophen HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Rhodes Pharms |
| April 17, 2015 | NDA205831 | Methylphenidate APTENSIO XR | Rhodes Pharms |
| August 28, 2014 | ANDA201278 | Oxycodone and acetaminophen OXYCODONE AND ACETAMINOPHEN | Rhodes Pharms |
| March 9, 2011 | ANDA091490 | Oxycodone hydrochloride OXYCODONE HYDROCHLORIDE | Rhodes Pharms |
| June 30, 2010 | NDA021306 | Buprenorphine BUTRANS | Knoa Pharma |
| May 13, 2005 | ANDA076433 | Fenofibrate FENOFIBRATE | Rhodes Pharms |
| July 7, 1998 | ANDA074862 | Morphine sulfate MORPHINE SULFATE | Rhodes Pharms |
| July 2, 1998 | ANDA074769 | Morphine sulfate MORPHINE SULFATE | Rhodes Pharms |
| December 7, 1992 | NDA019891 | Hydromorphone hydrochloride DILAUDID | Rhodes Pharms |
| December 7, 1992 | NDA019892 | Hydromorphone hydrochloride DILAUDID | Rhodes Pharms |
| May 29, 1987 | NDA019516 | Morphine sulfate MS CONTIN | Knoa Pharma |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
2021
-
August 19, 2021 · Class II · Terminated · D-0794-2021 · Oxycodone hydrochloride
Presence of Foreign Tablets/Capsules; A single foreign tablet Hydrochlorothiazide/Lisinopril 25/20 was found in one bottle
Oxycodone Hydrochloride Tablets, USP, 10 mg, 100 count bottle, Rx only, Marketed by: Rhodes Pharmaceuticals L.P., Coventry RI 02816, Manufactured by: Purdue Pharma L.P., Stanford, CT 06901 NDC 42858-002-01
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026